Florida / New York | ADVERTISE

A Publication for the Practising Medical Specialist, Industry Executive & Investor

Medical Device News Magazine is a digital Publication Founded in 2008, and proudly located in the United States

Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors. We take pride in offering high-quality, in-depth content, crafted by a team of experienced professionals. Our goal is to provide a unique perspective on the trends and innovations driving the future of medical technology. By reading our articles, you’re not only gaining exclusive industry insights but also becoming part of a community committed to advancing healthcare through groundbreaking technologies. Explore our content and consider partnering with us for advertising opportunities!

“Medical Device News: Essential Key Insights and Noteworthy Developments Shaping the Future”

Vitestro Unveils Aletta™

Vitestro Unveils Aletta ™ | World’s 1st Autonomous Robotic Phlebotomy Device

Aletta is the first and only Autonomous Robotic Phlebotomy Device™ (ARPD™), a unique technology descriptor that establishes a new category of medical robotics dedicated to optimizing blood collection. As the exclusive ARPD™, Aletta sets the global industry standard for automated venous blood draws—enhancing clinical precision, safety, efficiency, and patient experience.

Remote Monitoring Devices

Patients Transmit More Than 15 Million Vitals Using Pylo Remote Monitoring Devices

Patients use Pylo remote monitoring devices to collect and securely transmit health data like blood pressure, weight, blood glucose, oxygen saturation, and pulse rate readings to their care teams. With this data, providers can identify potential health issues early and intervene promptly, preventing potential hospitalizations.

PathMaker Neurosystems Announces Issuance of 3 Patents

“We are pleased to see these latest patent issuances that protect PathMaker’s novel technology for the non-invasive treatment of ALS,” said Jake Maslow, J.D., Co-Founder and Chief Intellectual Property Officer at PathMaker. “These patents provide additional protection specific to the treatment of ALS that goes beyond the more than 40 issued patents we already have protecting our platform globally.”

Clinical Trials

New Data From SonarMD Finds that Anxiety Increases Risks for Inflammatory Bowel Disease Flares and Disease Severity

“These findings demonstrate that mental health factors like anxiety play a critical role in the clinical course of IBD,” said Beth Houck, CEO, SonarMD “By identifying and addressing psychological contributors, we can refine value-based care models to better support patients with chronic digestive diseases. Integrated care models that incorporate mental health screening and interventions should be considered a standard for high-quality IBD care.”

Anocca Announces Submission of Clinical Trial Application for Multi-asset Trial VIDAR-1 in Advanced Pancreatic Cancer

Hugh Salter, Chief Scientific Officer at Anocca, elaborated, “KRAS is an immensely important target in many cancer types, but has to date been challenging to address. KRAS mutations are a hallmark of PDAC, which is among the most difficult to treat cancers, and we believe TCR-T cell therapies and, in particular, our VIDAR-1 assets can be effective in addressing this target and providing a new solution in an indication with high unmet medical need.”

Biotechnology News

EPO Grants Key CRISPR Patent to ERS Genomics CVC Portfolio

John E Milad, CEO of ERS Genomics, said: “The EPO’s decision to grant EP 4 289 948 with broad claims reinforces CVC’s leadership position in CRISPR IP in Europe and validates our strategic decision to self-revoke two legacy CRISPR/Cas9 patents. This decision provides our 150+ licensees with greater confidence in their rights, while maintaining CVC’s established patent leadership in Europe.”

Our Experts – Byline Articles

Read Their Views & Share With a Colleague or Two!

FDA Medical Device Updates

Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding

Digestiva Closes $18.4 million Series A Financing

Digestiva reports this significant milestone was led by Magdalena, a global leader in sugar cane processing, with participation from UC Investments, and existing investors The March Fund and Astanor. The company’s groundbreaking enzyme technology platform was initially discovered by co-founder Dr. Wilson Mak, in the lab of renowned UC Davis faculty member Dr. Justin Siegel, a global leader in enzyme discovery, development, and design.

Neuspera Medical Raises $23 Million in Series D Financing

Neuspera Medical notes this round will fund the company though expected U.S. Food and Drug Association (FDA) premarket approval (PMA) of the Neuspera System, the discreet, minimally invasive, ultra-miniaturized implant designed to provide patients personal control and relief from urinary urge incontinence (UUI), a symptom of overactive bladder (OAB).

Market Reports

Advancements in Imaging

Insightec MR-Guided Focused Ultrasound Technology Recommended for National Coverage for Dutch Patients Living with Essential Tremor

According to an Insightec study, patients experienced significant reductions in upper limb tremor, tremor-related disability, and quality of life. The most common intraprocedural adverse events included dizziness, headache, nausea, and vomiting, which all resolved. Post-procedural adverse events included paraesthesia and gait disturbance, which were often transient or resolved within 12 months.

Hospitals In the News

Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry

Non-Profit News

Healthcare - Understanding the Business Side of the Industry and Its Implications

Healthcare Careers

Nurses Corner

American Academy of Nursing

American Academy of Nursing Honors Exceptional Leaders with Annual Organizational Tributes

The American Academy of Nursing (Academy) will honor Eileen M. Sullivan-Marx, Representative Lauren Underwood, Kevin W. Sowers, Barbara Nichols, Jeri A. Milstead, and Winifred V. Quinn, with the organization’s prestigious annual awards during the 2023 Health Policy Conference, Celebrating 50 Years of Leadership, Policy, and Partnerships, being held October 5-7, 2023 in Washington, DC. Each awardee is being recognized for their invaluable contributions to improve care, advancing health equity, change health policy, and promote the nursing profession.

Health: A Comprehensive Exploration of Wellness, Nutrition, and Overall Well-Being for a Healthier Life

Articles Designed to Inspire and Guide You Toward Achieving Excellence and Success in All Your Endeavors.